Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal 
Berkshire Hathaway Eyes Bigger Stakes in Japan’s Top Trading Houses 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
American Airlines Eyes Capacity Cuts as High Fuel Prices Persist 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
White House Bars CNN, MS NOW and Politico Reporters 
Holtec Nuclear Postpones $900 Million U.S. IPO 
France Urges Faster AI Push Despite Safety Risks 
Guterres Urges Stronger Global AI Safeguards Ahead of UN Assembly 
SoftBank Launches $11 Billion Bond Sale to Fund OpenAI Investment 
US Federal Register Drops Alibaba Qwen AI Search Tool 
Cathie Wood Backs AI Slowdown as Safety Concerns Grow 
Volvo Cars Plans 13 New Models by 2030 to Boost Sales 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Westinghouse Targets $50 Billion Valuation in U.S. IPO 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Add as a preferred source on Google
Elon Musk’s brain-computer interface company Neuralink is preparing for a major expansion, announcing plans to begin high-volume production of its brain implant devices and transition to a fully automated surgical procedure by 2026. The announcement was made by Musk in a post on the social media platform X, highlighting the company’s long-term vision to scale its neurotechnology and make implantation faster, safer, and more accessible.
Neuralink’s brain implant technology is designed to help people with severe neurological conditions, including spinal cord injuries and paralysis, by enabling direct communication between the brain and external devices. The implant allows users to control digital tools using their thoughts, opening new possibilities for restoring independence and improving quality of life. According to previously shared updates, the first patient implanted with the device has successfully used it to play video games, browse the internet, post on social media, and control a laptop cursor without physical movement.
The company began human trials of its brain-computer interface in 2024 after resolving safety concerns raised by the U.S. Food and Drug Administration. The FDA had initially rejected Neuralink’s application in 2022, citing potential risks, but later approved the trials after additional safeguards were implemented. This marked a significant milestone for the company and the broader neurotechnology industry.
In September, Neuralink revealed that 12 people worldwide with severe paralysis had already received its brain implants. These individuals were reportedly using the technology to control both digital and physical tools purely through thought, demonstrating the real-world potential of brain-computer interfaces. The company has also attracted strong investor interest, securing $650 million in a funding round completed in June, further supporting its research, development, and manufacturing goals.
While Neuralink did not immediately respond to a request for comment, Musk’s statement suggests the company is moving toward large-scale deployment. If successful, high-volume production and fully automated surgical implantation could significantly accelerate adoption of brain implant technology, positioning Neuralink as a leader in the rapidly evolving field of neural interfaces and medical innovation.
